The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it none, with a mean price target of $17.
Select Medical Holdings Corporation SEM
Clears the common standard
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.
read at $16.51
Select Medical Holdings Corporation holds its Accumulation at $16.51.
- PHPhase · the trend structure carries the Accumulation label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 60 days |
| Price | $16.51 |
| Valuation | 15.43 trailing · 11.93 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.79 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our model and the Street both land near today's price — fairly valued, with no strong edge either way.
| Revenue growth | 5.00% |
| Profit margin | 2.42% |
| Debt to equity | 142.09 |
| Analyst consensus | None · 3 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
It depends which standard you follow. There are two widely recognised ways to check whether a company is suitable for a Muslim investor, and on this company they disagree. Here is how it did on each:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✓ PASSES
Why the two disagree. They fall out over one thing only: the company’s debt. Our stricter standard measures that debt against what the company owns, and it works out too high to pass. The common standard measures the same debt against what the company is worth on the stock market, where it works out low enough to pass. Every other check, the two agree on. So in practice, most halal apps would treat this as fine to hold, while our stricter view would not — and which line you follow is between you and your scholar.
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Against market value it is 146.2%, under the 30% line the market-value standard uses — so that standard clears it. Divergent
- Interest-bearing cash Interest-bearing cash and securities are of assets, above the one-third limit. Fail
- Receivables Money owed to the company is of assets, above the 49% limit. Fail
- Revenue purity Only 0.0% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Rehab Hospitals Trade at Break Even Value
Picture a patient moving from critical care into a specialist rehab bed. Select Medical runs those facilities across the United States, yet the shares sit dead on our fair value of 16.50 with a zero margin of safety. Forward earnings sit at 11.9 times, revenue grows only 5 percent, margins are just 2 percent and return on equity reaches 10 percent. No moat is visible and analysts see no upside from the current 16.51 price.
We pass because nothing in the numbers suggests the market has mispriced the business. Thin profitability and modest growth leave little room for error or outperformance. The ethical screen raises no flags, but that alone does not create an investment case when value and price already match.
Reimbursement pressure from insurers and government payers remains a standing risk in this sector. Any slowdown in patient volumes would hit the low margins quickly. Analysis, not advice.
| Forward P/E | 11.9x expensive even after accounting for its growth |
| Trailing P/E | 15.4x reasonably valued |
| Revenue growth | 5.0% slow but positive growth |
| Profit margin | 2.4% barely profitable |
| Return on equity | 9.8% a modest return on shareholder capital |
| Debt to equity | 1.42 a meaningful debt load worth watching |
| Current ratio | 1.15 adequate liquidity, worth monitoring |
| Beta | 0.79 steadier than the market |
| Market cap | $2.0B |
| Employees | 30,800 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in SEM's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
SEM trades on the NYSE. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 8 May2026 | Rick Allen | Republican | buy | 1K–15K |
| 8 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 30 Jun2026 | Gil Cisneros | Democrat | sell | 1K–15K |
| 2026-04-13 | Ro Khanna | Democrat | Purchase | 1K–15K |
| 2026-04-13 | Ro Khanna | Democrat | Purchase | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $16.38 | +1.4% | $0.06 | $1,017 | +1.7% |
| 2 months | $16.31 | +1.8% | $0.06 | $1,022 | +2.2% |
| 3 months | $16.18 | +2.6% | $0.06 | $1,030 | +3.0% |
| 6 months | $15.32 | +8.4% | $0.13 | $1,092 | +9.2% |
| 1 year | $15.14 | +9.7% | $0.25 | $1,113 | +11.3% |
| 2 years | $17.35 | -4.3% | $0.51 | $986 | -1.4% |
| 3 years | $14.57 | +13.9% | $0.78 | $1,193 | +19.3% |
| 5 years | $20.57 | -19.3% | $1.32 | $871 | -12.9% |
Historical returns from market close data. Past performance does not guarantee future results.